To understand the interactions between substance P and gut inflammation, changes in substance P levels were evaluated in a chronic model of ileitis in response to three anti-inflammatory agents with distinct mechanisms of action. The agents were the prostaglandin Et analogue misoprostol (30 #g/kg, s.c., b.i.d.), the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME, 100 #g/ml in drinking water) and the leumedin, N-(fluorenyl-9-methoxycarbonyl)-L-leucine (NPC 15199, 10mg/kg, s.c.). Ileitis was induced by a transmural injection of trinitrobenzene sulphonic acid (TNBS 30mg/kg in 50% ethanol) into the distal ileum of guinea-pigs. All anti-inflammatory therapies were introduced after TNBS administration and continued until day 7, when guinea-pigs were killed. Ileal substance P levels were measured by radioimmunoassay, and granulocyte infiltration was quantified by myeloperoxidase (MPO) activity. Protein and nitrite (an index of nitric oxide formation) levels in a luminal saline lavage were quantified in all groups. TNBS ileitis caused a marked reduction in ileal substance P content and increased MPO activity, protein and nitrite secretion. The nitric oxide synthase inhibitor, L-NAME, completely restored all parameters to baseline, iisoprostol attenuated the granulocyte infiltration and exacerbated protein leak but had no effect on substance P levels. In contrast, NPC 15199 had no effect on granulocyte infiltration but normalized substance P levels and protein leak. Only L-NAME and NPC 15199 blocked the TNBS induced increase in nitrite levels. These results suggest that the regulation of granulocyte infiltration in this model is unrelated to changes in substance P levels. Inhibition of nitric oxide synthase was the most effective therapeutic strategy in TNBS ileitis but the precise interactions between nitric oxide and the enteric nervous system during inflammatory states remain to be defined.
To understand the interactions between substance P and gut inflammation, changes in substance P levels were evaluated in a chronic model of ileitis in response to three anti-inflammatory agents with distinct mechanisms of action. The agents were the prostaglandin Et analogue misoprostol (30 #g/kg, s.c., b.i.d.), the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME, 100 #g/ml in drinking water) and the leumedin, N-(fluorenyl-9-methoxycarbonyl)-L-leucine (NPC 15199, 10mg/kg, s.c.). Ileitis was induced by a transmural injection of trinitrobenzene sulphonic acid (TNBS 30mg/kg in 50% ethanol) into the distal ileum of guinea-pigs. All anti-inflammatory therapies were introduced after TNBS administration and continued until day 7 , when guinea-pigs were killed. Ileal substance P levels were measured by radioimmunoassay, and granulocyte infiltration was quantified by myeloperoxidase (MPO) activity. Protein and nitrite (an index of nitric oxide formation) levels in a luminal saline lavage were quantified in all groups. TNBS ileitis caused a marked reduction in ileal substance P content and increased MPO activity, protein and nitrite secretion. The nitric oxide synthase inhibitor, L-NAME, completely restored all parameters to baseline, iisoprostol attenuated the granulocyte infiltration and exacerbated protein leak but had no effect on substance P levels. In contrast, NPC 15199 had no effect on granulocyte infiltration but normalized substance P levels and Lavage nitrite levels were also elevated above baseline in TNBS ileitis (p < 0.05). This response was unaltered by misoprostol treatment but completely prevented by either L-NAME or NPC 15199 administration (p < 0.05, Fig. 4 ). Table 1 summarizes the markers of gut inflammation and the influence of the therapeutic approaches.
Morphologically, only L-NAME restored normal gut appearance; in either NPC 15199 or misoprostol treated animals the crypt hypertrophy, submucosal fibrosis and smooth muscle hyperplasia that are associated with TNBS ileitis were readily apparent. , L-NAME (100#g/ml in drinking water, ad libitum) or NPC 15199 (10 mg/kg, s.c.). All groups were treated for 7 days. Significant difference from control (sham) animals (p < 0.05).
Significant difference between TNBS alone vs. TNBS with drug therapy (p< 0.05). I-I, Control; B, TNBS; I1., TNBS + MISO; I'FI, TNBS + L-NAME; I, TNBS+NPC 15199. Arrows indicate the direction of change, the number of arrows indicate the magnitude of an alteration from control guinea-pigs.
Discussion
One week after induction of ileitis with TNBS intestinal substance P content was markedly reduced. This primarily reflects alterations in submucosal substance P and to a lesser extent mucosal sites, because it has been .noted previously that rnyenteric plexus substance P content remains unaltered. 6 The present study was designed to determine the relationship between these changes in ileal substance P and the inflammatory process, through the use of three structurally and mechanistically different non-steroidal anti-inflammatory agents.
Perhaps the most intriguing finding was that the degree of granulocyte infiltration was unrelated to the reductions in substance P content. This finding was revealed by comparing the effects of misoprostol and NPC 15199. Misoprostol attenuated ileal MPO levels but had no effect on the substance P response, whereas NPC 15199 had no effect on MPO levels but normalized ileal substance P levels. 
